Reuters Health: COVID vaccine proved safe, well tolerated in patients with rheumatic diseases

UC expert recommends further study differentiates between treatment, disease types

A new European study recently published in the Annals of Rheumatic Diseases shows that currently available COVID-19 vaccines rarely cause flares in patients with rheumatic and musculoskeletal disease. Flares were reported in less than 5% of all cases within the study.

While encouraging, Wenhai Shao, PhD, associate professor in the Division of Immunology, Allergy and Rheumatology in the University of Cincinnati's Department of Internal Medicine, told Reuters Health that further studies should differentiate whether patients are taking immunosuppressants or other types of drugs, compare to healthy individuals and note the severity of the rheumatic or musculoskeletal diseases when the vaccination was given for more specific results.

"A bioinformatics approach could be used to analyze the data in these different ways," Shao said.

Read the Reuters Health article.

Featured photo at top of vaccination courtesy of Shutterstock.com 

Related Stories

1

CCM hosts Moveable Feast gala fundraiser on Jan. 24, 2025

Event: January 24, 2025 12:00 AM

UC College-Conservatory of Music hosts its Moveable Feast fundraising gala live and in-person on Friday, Jan. 24, 2025. Presented by CCMpower, a dedicated volunteer group of friends, advocates and alumni, Moveable Feast 2025: A Tempo generates essential support for the next generation of performing and media artists at CCM. Learn more about the event's "artistic menu" in our digital program!

Debug Query for this